Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Completed
Phase 2

Conditions

Opioid-Related Disorders
Substance-Related Disorders

Treatments

Drug: Buprenorphine

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00000318
R01-09803-1
NIDA-09803-1

Details and patient eligibility

About

The purpose of this study is to assess optimal dosage of buprenorphine on a thrice weekly schedule in a pilot clinical trial.

Enrollment

202 patients

Sex

All

Ages

21 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

None (Open label)

202 participants in 2 patient groups

1
Experimental group
Description:
Maintenance treatment with daily medication
Treatment:
Drug: Buprenorphine
2
Experimental group
Description:
Maintenance treatment with thrice-weekly medication
Treatment:
Drug: Buprenorphine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems